secretagogue is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-07-12. Numbers and descriptions here follow the published literature rather than marketing material.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.
Research peptides such as ipamorelin are commonly supplied as lyophilized powder and characterized by analytical certificates. Reversed-phase high-performance liquid chromatography is used to estimate purity by ultraviolet absorbance, while mass spectrometry confirms molecular identity and detects sequence-related impurities. Counterion content, water content, and residual synthesis reagents can affect the reported mass balance. A certificate of analysis may list a purity percentage, but that number depends on the analytical method and the definition of impurity peaks. Independent verification is often recommended because research supply chains vary in quality control practices.
Storage recommendations for ipamorelin usually focus on temperature, moisture, and light. Lyophilized powder is typically held at or below minus twenty degrees Celsius in a desiccated container protected from light. Reconstituted solutions are often aliquoted and stored at minus eighty degrees Celsius to reduce repeated freeze-thaw cycles, which can promote aggregation or degradation. The optimal buffer and pH depend on the specific assay, and no single condition applies to every experimental context. Peptide stability should be assessed with time-point measurements rather than assumed from general handling rules.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Pentapeptide with C-terminal amide |
| Average mass | Approximately 711.9 Da | Value derived from the formula |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water and aqueous acetonitrile | Dissolution aided by acidic diluents |
| Common synonyms | Ipamorelin; NNC 26-0161 | Code name used in early reports |
Long-term storage of the dry powder is typically at minus twenty degrees Celsius or lower, protected from light and moisture. Solutions are commonly kept frozen and thawed only once, because repeated freeze-thaw cycles can promote aggregation and loss of measurable peptide content. Buffers near neutral pH are preferred over strongly acidic or strongly basic conditions. Shipping at ambient temperature is acceptable for short periods when the powder remains sealed and desiccated.
Identity and purity are assessed by complementary methods rather than a single test. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and reports a percentage purity. Mass spectrometry, most often with electrospray ionization, confirms the expected molecular mass and detects sequence-related variants. Amino acid analysis can verify composition, while water content and residual counterion measurements support the mass balance of a batch. Stability studies under accelerated conditions are used to estimate shelf life, though such estimates carry uncertainty for long-term storage.
Most published work on ipamorelin comes from rodent studies and small early-phase human trials. Subcutaneous and intravenous routes have been used, while oral delivery is limited by poor absorption and rapid breakdown in the gut. The reported plasma half-life is short, on the order of two hours, and varies with species and assay method. Whether chronic use produces meaningful clinical benefit remains unresolved, and long-term safety data in humans are sparse. No major regulatory agency has approved the compound as a therapeutic drug.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues that resist enzymatic breakdown. Researchers at Novo Nordisk described the compound in the 1990s while searching for agents that release growth hormone with fewer side effects than earlier secretagogues. The molecule acts as an agonist at the ghrelin receptor, also called GHS-R1a, which is expressed in the pituitary and in several peripheral tissues.
Selectivity distinguishes ipamorelin from first-generation secretagogues such as GHRP-6. At doses that reliably raise growth hormone, it shows little stimulation of adrenocorticotropic hormone or cortisol release in animal models, and it does not markedly raise prolactin or appetite. Binding at GHS-R1a on pituitary somatotrophs triggers calcium influx and pulsatile growth hormone secretion. Because the compound mimics the natural ghrelin signal, the release pattern tends to follow the body's own rhythm rather than producing a sustained elevation.
== External links == "GenAge entry for CAT (Homo sapiens)". Human Ageing Genomic Resources. Retrieved 2009-03-05. "Catalase". MadSci FAQ. madsci.org. Archived from the original on 2009-03-09. Retrieved 2009-03-05. "Catalase and oxidase test video". Regnvm Prokaryotae. Retrieved 2009-03-05. "EC 1.11.1.6 - catalase". Brenda: The Comprehensive Enzyme Information System. Retrieved 2009-03-05. "PeroxiBase - The peroxidase database". Swiss Institute of Bioinformatics. Archived from the original on 2008-10-13. Retrieved 2009-03-05. "Catalase Procedure". MicrobeID.com. Retrieved 2009-04-22. "Catalase Molecule of the Month". Protein Data Bank. Archived from the original on 2013-05-11. Retrieved 2013-01-08. Overview of all the structural information available in the PDB for UniProt: P04040 (Catalase) at the PDBe-KB.
The discipline of plant ecology was pioneered in the late 19th century by botanists such as Eugenius Warming, who produced the hypothesis that plants form communities, and his mentor and successor Christen C. Raunkiær whose system for describing plant life forms is still in use today. The concept that the composition of plant communities such as temperate broadleaf forest changes by a process of ecological succession was developed by Henry Chandler Cowles, Arthur Tansley and Frederic Clements. Clements is credited with the idea of climax vegetation as the most complex vegetation that an environment can support and Tansley introduced the concept of ecosystems to biology. Building on the extensive earlier work of Alphonse de Candolle, Nikolai Vavilov (1887–1943) produced accounts of the biogeography, centres of origin, and evolutionary history of economic plants. Particularly since the mid-1960s there have been advances in understanding of the physics of plant physiological processes such as transpiration (the transport of water within plant tissues), the temperature dependence of rates of water evaporation from the leaf surface and the molecular diffusion of water vapour and carbon dioxide through stomatal apertures. These developments, coupled with new methods for measuring the size of stomatal apertures, and the rate of photosynthesis have enabled a precise description of the rates of gas exchange between plants and the atmosphere.
The forced sterilization policy under Peruvian president Alberto Fujimori affected almost exclusively Quechua and Aymara women, a total of about 270,000 (and 22,000 men) according to official figures. The sterilization program lasted for over five years between 1996 and 2001. During this period, women were coerced into forced sterilization. Sterilizations were often performed under dangerous and unsanitary conditions, as the doctors were pressured to perform operations under unrealistic government quotas, which made it impossible to properly inform women and receive their consent. The Bolivian film director Jorge Sanjinés dealt with the issue of forced sterilization in 1969 in his Quechua-language feature film Yawar Mallku. Quechuas have been left out of their nation's regional economic growth in recent years. The World Bank has identified eight countries on the continent to have some of the highest inequality rates in the world. The Quechuas have been subject to these severe inequalities, as many of them have a much lower life expectancy than the regional average, and many communities lack access to basic health services. Perceived ethnic discrimination continues to play a role at the parliamentary level. When the newly elected Peruvian members of parliament Hilaria Supa Huamán and María Sumire swore their oath of office in Quechua—for the first time in the history of Peru in an Indigenous language—the Peruvian parliamentary president Martha Hildebrandt and the parliamentary officer Carlos Torres Caro refused their acceptance.
Sources: en.wikipedia.org
Most of the antiviral drugs now available are designed to help deal with HIV, herpes viruses, the hepatitis B and C viruses, and influenza A and B viruses. Viruses use the host's cells to replicate and this makes it difficult to find targets for the drug that would interfere with the virus without also harming the host organism's cells. Moreover, the major difficulty in developing vaccines and antiviral drugs is due to viral variation. The emergence of antivirals is the product of a greatly expanded knowledge of the genetic and molecular function of organisms, allowing biomedical researchers to understand the structure and function of viruses, major advances in the techniques for finding new drugs, and the pressure placed on the medical profession to deal with the human immunodeficiency virus (HIV), the cause of acquired immunodeficiency syndrome (AIDS). The first experimental antivirals were developed in the 1960s, mostly to deal with herpes viruses, and were found using traditional trial-and-error drug discovery methods. Researchers grew cultures of cells and infected them with the target virus. They then introduced into the cultures chemicals which they thought might inhibit viral activity and observed whether the level of virus in the cultures rose or fell. Chemicals that seemed to have an effect were selected for closer study. This was a very time-consuming, hit-or-miss procedure, and in the absence of a good knowledge of how the target virus worked, it was not efficient in discovering effective antivirals which had few side effects.
P. s. pv. aceris attacks maple Acer species. P. s. pv. actinidiae attacks kiwifruit Actinidia chinensis. P. s. pv. aesculi attacks horse chestnut Aesculus hippocastanum, causing bleeding canker. P. s. pv. aptata attacks beets Beta vulgaris. P. s. pv. atrofaciens attacks wheat Triticum aestivum. P. s. pv. dysoxylis attacks the kohekohe tree Dysoxylum spectabile. P. s. pv. glycinea attacks soybean Glycine max, causing bacterial blight of soybean. P. s. pv. japonica attacks barley Hordeum vulgare. P. s. pv. lapsa attacks wheat Triticum aestivum. P. s. pv. panici attacks Panicum grass species. P. s. pv. papulans attacks crabapple Malus sylvestris species. P. s. pv. persicae attacks nectarine and peach. P. s. pv. phaseolicola causes halo blight of beans. P. s. pv. pisi attacks peas Pisum sativum. P. s. pv. syringae attacks Syringa, Prunus, and Phaseolus species. P. s. pv. tomato attacks tomato. However, many of the strains for which new species groupings were proposed continue to be referred to in the scientific literature as pathovars of P. syringae, including pathovars tomato, phaseolicola, and maculicola. Pseudomonas savastanoi was once considered a pathovar or subspecies of P. syringae, and in many places continues to be referred to as P. s. pv. savastanoi, although as a result of DNA-relatedness studies, it has been instated as a new species. It has three host-specific pathovars: P. s. fraxini (which causes ash canker), P. s. nerii (which attacks oleander), and P. s. oleae (which causes olive knot).
In June 2023, Collins attended the Animal Ball at Lancaster House in support of Elephant Family, a charity dedicated to protecting the Asian elephant from extinction. During the event, she met Charles III and Queen Camilla, with whom she discussed her elephant sculptures she purchased in support of the organisation, before inviting them to go on a safari with her. Collins has been a long-time supporter of Camp Beagle, a protest camp set up by animal rights activists who campaign for the closure of MBR Acres, a breeding facility for beagles used in laboratory research. In February 2024, she gave a speech at the rally outside of the Houses of Parliament where she encouraged people to "keep making noise" about MBR Acres and vowed to "Save the Beagles" by ensuring its closure, prior to attending the parliamentary debate to ban toxicology tests on animals. In April 2024, Collins became an ambassador for "Bark for Our Parks", a campaign for the charity Fields in Trust which protects parks and green spaces. The campaign encouraged owners and their dogs to embark on walking 50km or 100km as part of a fundraiser. Speaking of the campaign, Collins said she was "so excited to be welcomed into the Fields in Trust family as a Bark For Our Parks ambassador", and added that "the highlight of [her dog] Blue's day, and often her own was exploring their local parks and green spaces, so [she was] really happy that [she got] to be a part of this wonderful initiative helping to make sure our walkies will be here forever.
==== United States ==== Gabapentin is not a controlled substance under the federal Controlled Substances Act. Effective in July 2017, Kentucky classified gabapentin as a Schedule V controlled substance statewide. Gabapentin is a schedule V drug in other states such as West Virginia, Tennessee, Alabama, Utah, and Virginia.
Sources: en.wikipedia.org
Nights were spent camping on riverbanks, where hammocks were usually slung between trees or, when trees were absent, from canoe paddles or on ox-hides. This exposed the expedition to risks from snakes, alligators, and jaguars, which were especially prevalent and feared by local Natives. Nighttime was often unsettled due to animal activity, including monkeys, peccaries, sloths, and birds.Shortly after departure, a sudden squall nearly overturned the canoe, but a shift in wind stabilized the vessel. The following morning, the expedition encountered a Carib family traveling from the mouth of the Orinoco to collect turtle eggs, an event that attracted hundreds of Natives from various tribes and a few white traders. The eggs were rendered for oil, used for cooking and lighting, though overharvesting threatened the turtle population. At the Island of the Tortoises, Native tribes gathered annually to harvest turtle eggs, each tribe distinguished by unique body paint. Humboldt observed the process and noted that the previous Jesuit supervisors had ensured some eggs were left to hatch, but that their successors, the Franciscans, did not exercise such care, causing a decline in the turtle population. The Native crew from San Fernando departed at the turtle islands, as they lacked experience with the rapids ahead. The expedition switched to a smaller, less comfortable canoe, fashioned from a single tree trunk, which further limited space and increased exposure to environmental discomforts.
== Goals == The goals of the BRSD are the separation of church and state, the democratization of the church, the political neutrality of the church, non-denominational schools, an end of the chaplaincy and for the church to work for peace and international understanding.
Urocanase (also known as imidazolonepropionate hydrolase or urocanate hydratase) is the enzyme (EC 4.2.1.49) that catalyzes the second step in the degradation of histidine, the hydration of urocanic acid to imidazol-4-one-5-propionic acid. Urocanase is coded for by the UROC1 gene, located on the third chromosome in humans. The protein itself is composed of 676 amino acids which then fold, producing the final product which has two identical subunits, making the enzyme a homodimer. To catalyze the hydrolysis of urocanate in the catabolic pathway of L-histidine the enzyme utilizes its two nicotinamide adenine dinucleotide (NAD+) groups. These act as electrophiles, attaching to the top carbon of the urocanate which leads to sigmatropic rearrangement of the urocanate molecule. This rearrangement allows for the addition of a water molecule, converting the urocanic acid into imidazol-4-one-5-propionic acid.
=== Fretta Contest and Trouble in Terrorist Town === In late 2009, Facepunch launched the "Fretta Contest", a competition in which people were to develop Garry's Mod game modes using the proprietary Fretta programming framework, with the winning game mode to be added to the base game. The winner of this contest was Trouble in Terrorist Town (TTT), which was added to the game in July 2010, alongside another mode, Dogfight: Arcade Assault. TTT assigns players to three groups: Traitors, Detectives, and Innocents, similar to the party game Mafia. Detectives are known to all players, whereas Traitors are only known to other Traitors and otherwise appear as Innocents. While Traitors attempt to eliminate all other players, Innocents and Detectives need to co-operate to identify and eliminate all Traitors. To do the latter, Detectives are given special equipment, such as DNA scanners that can trace a dead player's killer.
Many of the medications used in feminizing hormone therapy, such as estradiol, cyproterone acetate, and bicalutamide, are substrates of CYP3A4 and other cytochrome P450 enzymes. As a result, inducers of CYP3A4 and other cytochrome P450 enzymes, such as carbamazepine, phenobarbital, phenytoin, rifampin, rifampicin, and St. John's wort, among others, may decrease circulating levels of these medications and thereby decrease their effects. Conversely, inhibitors of CYP3A4 and other cytochrome P450 enzymes, such as cimetidine, clotrimazole, grapefruit juice, itraconazole, ketoconazole, and ritonavir, among others, may increase circulating levels of these medications and thereby increase their effects. The concomitant use of a cytochrome P450 inducer or inhibitor with feminizing hormone therapy may necessitate medication dosage adjustments.
Sources: en.wikipedia.org
It is a synthetic five-amino-acid peptide that acts as a growth hormone secretagogue. Three of its residues are non-standard amino acids, and the chain ends in an amide rather than a free acid. The molecule is small enough that it can be characterised by routine peptide analytical techniques.
It has not received marketing approval as a medicine in the United States or the European Union. Supplied material is generally described and handled as a research chemical. Regulatory treatment varies by jurisdiction, and some countries restrict growth hormone secretagogues under sports or medicines legislation.
Earlier secretagogues were associated with broader hormonal responses, including measurable changes in cortisol and prolactin. Reports on this peptide describe a narrower profile in which growth hormone release is the most prominent effect. The observation is influential because it shapes how the compound is compared with other members of the same receptor family.
Purity is commonly estimated by reversed-phase high-performance liquid chromatography with ultraviolet detection. Mass spectrometry is used to confirm identity and to detect sequence-related impurities. Reported percentages depend on the method and the impurity threshold used.